Lexaria Bioscience Corp. (LEXXW) Financials

$0.32

south_east
-$0.03 (-9.14%)
Day's range
$0.3
Day's range
$0.44
$2M$2M$0$0-$2M-$2M-$4M-$4M-$6M-$6M-$8M-$8MEarning201820182019201920202020202120212022202220232023202420240%0%-1000%-1000%-2000%-2000%-3000%-3000%-4000%-4000%-5000%-5000%Profit Margin
Profit Margin
Revenue
Earnings

LEXXW Income statement / Annual

Last year (2024), Lexaria Bioscience Corp.'s total revenue was $464,278.00, an increase of 105.24% from the previous year. In 2024, Lexaria Bioscience Corp.'s net income was -$5.80 M. See Lexaria Bioscience Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 08/31/2024 08/31/2023 08/31/2022 08/31/2021 08/31/2020 08/31/2019 08/31/2018 08/31/2017 08/31/2016 08/31/2015
Operating Revenue $464,278.00 $226,208.00 $255,397.00 $722,738.00 $384,543.00 $222,610.00 $433,287.00 $63,639.00 $40,718.00 $14,702.00
Cost of Revenue $4,822.00 $31,500.00 $71,841.00 $175,346.00 $99,378.00 $22,893.00 $25,185.00 $29,750.00 $45,615.00 $29,883.00
Gross Profit $459,456.00 $194,708.00 $183,556.00 $547,392.00 $285,165.00 $199,717.00 $408,102.00 $33,889.00 -$4,897.00 -$15,181.00
Gross Profit Ratio 0.99 0.86 0.72 0.76 0.74 0.9 0.94 0.53 -0.12 -1.03
Research and Development Expenses $2.36 M $3.67 M $1.84 M $1.26 M $387,074.00 $555,730.00 $492,864.00 $54,185.00 $9,024.00 $146,466.00
General & Administrative Expenses $3.85 M $3.06 M $5.72 M $4.97 M $3.57 M $3.13 M $6.02 M $1.63 M $1.01 M $1.49 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $204,277.00 $515,360.00 $489,058.00 $209,034.00 $185,459.00 $276,560.00
Selling, General & Administrative Expenses $3.85 M $3.06 M $5.72 M $4.97 M $3.77 M $3.64 M $6.51 M $1.84 M $1.20 M $1.76 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $112,750.00 $60,550.00 $2,307.00 -$886.00 $4,602.00 -$22,664.00
Operating Expenses $6.21 M $6.73 M $7.57 M $6.23 M $4.27 M $4.26 M $7.01 M $1.90 M $1.21 M $1.91 M
Cost And Expenses $6.22 M $6.76 M $7.64 M $6.41 M $4.37 M $4.28 M $7.03 M $1.92 M $1.26 M $1.94 M
Interest Income $14,311.00 $43,190.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6,015.00 $2,250.00 $31,544.00
Depreciation & Amortization $76,153.00 $145,397.00 $146,914.00 $147,597.00 $146,092.00 $60,550.00 $2,307.00 $1,488.00 $619.00 -$22,664.00
EBITDA -$5.68 M -$6.39 M -$6.52 M -$5.58 M -$4.00 M -$4.10 M -$6.61 M -$1.92 M -$1.26 M -$1.95 M
EBITDA Ratio -12.23 -28.24 -28.36 -9.77 -9.83 -17.52 -15.23 -29.22 -29.84 -132.69
Operating Income Ratio -12.39 -28.89 -28.91 -7.87 -10.12 -17.79 -15.23 -29.25 -29.85 -131.15
Total Other Income/Expenses Net -$55,524.00 -$178,503.00 -$764,614.00 $1.52 M $0.00 -$228,060.00 -$8,968.00 -$6,015.00 -$34,698.00 -$55,058.00
Income Before Tax -$5.81 M -$6.71 M -$7.38 M -$4.16 M -$4.08 M -$4.16 M -$6.61 M -$1.93 M -$1.28 M -$1.98 M
Income Before Tax Ratio -12.51 -29.67 -28.91 -5.76 -10.62 -18.68 -15.25 -30.32 -31.37 -134.9
Income Tax Expense $0.00 $0.00 -$114,329.00 -$1.66 M -$54,286.00 $39,623.00 -$8,968.00 -$54,173.00 -$60,226.00 -$181,226.00
Net Income -$5.80 M -$6.66 M -$7.27 M -$2.50 M -$4.03 M -$4.20 M -$6.60 M -$1.87 M -$1.21 M -$1.77 M
Net Income Ratio -12.48 -29.46 -28.46 -3.47 -10.48 -18.86 -15.23 -29.37 -29.83 -120.43
EPS -0.47 -1.01 -1.24 -0.57 -1.45 -1.62 -2.79 -0.95 -0.83 -1.34
EPS Diluted -0.47 -1.01 -1.24 -0.57 -1.45 -1.62 -2.79 -0.95 -0.83 -1.34
Weighted Average Shares Out $12.38 M $6.61 M $5.89 M $4.39 M $2.77 M $2.59 M $2.37 M $1.96 M $1.46 M $1.32 M
Weighted Average Shares Out Diluted $12.38 M $6.61 M $5.89 M $4.39 M $2.77 M $2.59 M $2.37 M $1.96 M $1.46 M $1.32 M
Link